JULIANE LÉGER
Professor Juliane Léger is the head of the French National Reference Centre of Growth and Development Endocrine Disorders and co-chair of the Paediatric Endocrinology Diabetology department at the Robert Debré University Hospital in Paris.
She is an active member of the European society for Paediatric Endocrinology, the Endocrine Society and the Growth hormone Research Society for many years and also serves as Editor for the European Journal of Endocrinology.
Her research interests include various aspects of thyroid, pituitary and pubertal diseases management and epidemiology of rare growth endocrine disorders.
Sponsored by 
ANDREW DAUBER
Dr. Dauber is currently an Associate Professor in the Division of Endocrinology at Cincinnati Children’s Hospital Medical Center as well the Program Director of The Cincinnati Center for Growth Disorders. Dr. Dauber earned his MD and a Master’s degree in clinical investigation at Harvard Medical School. He completed his pediatrics residency, chief residency, and pediatric endocrinology fellowship training at Boston Children’s Hospital.
At Boston Children’s Hospital, Dr. Dauber began his research career in the laboratory of Joel Hirschhorn. Dr. Dauber’s work focuses on rare genetic causes of growth disorders and the use of next generation sequencing technologies to understand pediatric endocrine disorders. He has identified numerous genetic etiologies for short stature in addition to discovering that mutations in the MKRN3 gene are responsible for central precocious puberty. In acknowledgment of his work, Dr. Dauber has earned multiple awards including young investigator awards from the Endocrine Society, the American Society of Clinical Investigation, and the European Society of Pediatric Endocrinology.
Sponsored by 
CARLO ACERINI
Dr Carlo Acerini is a Senior Lecturer at the University of Cambridge and a Consultant Paediatrician (Endocrinology & Diabetes) at Addenbrooke's Hospital, Cambridge. As an undergraduate he read Pharmacology and then Medicine at the University of Dundee before completing his postgraduate training in paediatrics in the West of Scotland and as a clinical research fellow in paediatric endocrinology and diabetes at the Universities of Oxford and Cambridge.
Dr Acerini is actively involved in clinical research in the areas of paediatric and adolescent diabetes and endocrinology, including studies on the development of new therapeutic approaches for the management of young people with Type 1 diabetes, such as the artificial pancreas research programme in Cambridge.
His roles within paediatric diabetes have included the ISPAD Advisory council (2005-07 & 2010-12), as a co-editor of the 2014 ISPAD Clinical Practice Consensus Guidelines, and as an Associate Editor for the journal Diabetic Medicine. He was also recent past Secretary to the British Society of Paediatric Endocrinology and Diabetes (2011-2016).
Sponsored by 
RACHEL GAFNI
Rachel I. Gafni received her BA from Barnard College and her MD from Temple University School of Medicine. She completed a pediatric residency at the Children’s Hospital of Philadelphia followed by a pediatric endocrinology fellowship at the National Institutes of Health (NIH), serving as an officer in the United States Public Health Service from 1996-2002. She subsequently served as an Assistant Professor at the University of Maryland for 5 years. Dr. Gafni returned to the NIH in 2007 as an investigator in the National Institute of Dental and Craniofacial Research. She is faculty in the NIH Pediatric Endocrinology and NIH Inter-institute Adult Endocrinology Training Programs. Dr. Gafni is a principal or associate investigator investigator on several research protocols treating patients with endocrine disorders including hypoparathyroidism, osteoporosis, McCune-Albright Syndrome, hypophosphatemic rickets, tumor-induced osteomalacia, hyperphosphatemic familial tumoral calcinosis, generalized arterial calcification of infancy, and other metabolic bone diseases.
